(1 - 14 von 16
)
177Lutetium-Octeotrate May Be Practice-Changing for Advanced ...www.cancertherapyadvisor.com › ... › ESMO 2022
www.cancertherapyadvisor.com
· ... could be practice-changing in this setting, according to Eric Baudin, MD, PhD, of Gustave Roussy – Cancer Campus in Villejuif, France.
History of Changes for Study: NCT ClinicalTrials.govclinicaltrials.gov › history › NCT
clinicaltrials.gov
Study Officials: Eric BAUDIN, MD Principal Investigator Gustave Roussy, Cancer Campus, Grand Paris. Locations: France, Val de Marne. Gustave Roussy
sortiert nach Relevanz / Datum